Tips for Tablets

Spray coating is a critical step in the pharmaceutical manufacturing process, particularly when applying coatings to tablets. Achieving a uniform coating thickness is essential to ensure consistent drug release, tablet integrity, and product aesthetics. However, uneven coating thickness can lead to several issues, such as poor dissolution profiles, mechanical instability, and cosmetic defects. One of the primary contributors to non-uniform coatings is improper spray gun settings during the coating process. Optimizing these settings is crucial for achieving consistent and uniform coating thickness on tablets.
Click to read the full article.

Sugar coating is a widely used technique in pharmaceutical manufacturing to coat tablets, providing them with a sweet taste, a smooth finish, and protection against environmental factors. However, one of the challenges faced during the sugar-coating process is core erosion, where the tablet’s core or surface becomes damaged due to excessive moisture, mechanical stress, or improper coating procedures. Core erosion can lead to issues such as uneven coating thickness, compromised tablet integrity, and a poor appearance of the final product. Addressing this issue is essential to ensure the quality and uniformity of the coated tablets.
Click to read the full article.

Tablet compaction and compression are critical steps in pharmaceutical manufacturing that directly influence tablet quality, including hardness, dissolution, and bioavailability. The size and distribution of the particles in the powder blend used for tablet formation play a significant role in the compaction process. Particle size can impact the flowability, packing density, and inter-particulate bonding, all of which are essential for achieving the desired tablet properties. Improper control of particle size during formulation can lead to poor compaction, inconsistent tablet weight, and undesirable tablet characteristics.
Click to read the full article.

Granule segregation is a common issue in the pharmaceutical manufacturing process, particularly during the drying and granulation stages. This problem becomes even more pronounced in fluidized bed systems, where powders or granules are suspended and dried through the flow of heated air. In a fluidized bed, improper particle movement or distribution can lead to granule segregation, where particles of different sizes, densities, or compositions separate during processing. This segregation can result in inconsistent product quality, such as uneven drug distribution, altered dissolution rates, or poor tablet cohesion. Addressing granule segregation is crucial for maintaining the uniformity and effectiveness of the final pharmaceutical product.
Click to read the full article.

In pharmaceutical manufacturing, cross-contamination poses a significant risk, especially in facilities where multiple products are manufactured in the same space. The unintended transfer of substances from one product batch to another can lead to serious consequences such as compromised product quality, regulatory non-compliance, and, in the worst case, harm to patients. Cross-contamination risks are particularly high in shared manufacturing facilities, where different products, APIs, or excipients are processed using similar equipment or in close proximity.
Click to read the full article.

High-speed coating machines are widely used in pharmaceutical manufacturing to apply coatings to tablets for various purposes such as taste masking, controlled release, and enteric protection. However, during the coating process, a significant issue that arises is tacking, where the coated tablets stick to each other, causing defects in the final product. This issue is especially prevalent in high-speed coating machines, where rapid rotation and high air pressure can cause the coating to become tacky before it has dried properly. To overcome this challenge, the use of anti-tacking agents is crucial. These agents help prevent the tablets from sticking together, ensuring smooth and uniform coating applications.
Click to read the full article.

Enteric-coated tablets are designed to protect the active pharmaceutical ingredient (API) from degradation in the stomach and to ensure that the drug is released in the intestines. However, one common issue in the production of enteric-coated tablets is adhesion failure, where the coating does not properly adhere to the tablet core. Adhesion failure can lead to incomplete or uneven coatings, which can affect the tablet’s release profile, stability, and effectiveness. Identifying the causes of adhesion failure and implementing appropriate solutions is crucial to ensuring the quality and performance of enteric-coated tablets.
Click to read the full article.

Electrostatic charge accumulation in powder blends is a significant challenge in pharmaceutical manufacturing, especially during processes like powder blending. This charge can lead to powder clumping, inconsistent flow, and poor blend uniformity, which ultimately affects tablet formation and product quality. When powders become electrostatically charged, they may adhere to equipment surfaces, leading to material loss, contamination, and inconsistent mixing. Addressing electrostatic charge in powder blending is crucial to ensure efficient processing, uniform mixing, and consistent tablet quality.
Click to read the full article.

Overloading in tablet press hoppers is a common issue in tablet manufacturing that can lead to a variety of operational problems, such as inconsistent tablet weight, reduced tablet quality, and increased wear and tear on equipment. The hopper is responsible for feeding the powder blend into the tablet press machine, where it is compressed into tablets. Overloading occurs when the hopper is filled beyond its optimal capacity, which can cause the powder blend to flow inconsistently, resulting in uneven tablet formation and other defects. Preventing overloading in the hopper is crucial to maintaining consistent tablet quality, optimizing machine efficiency, and minimizing downtime.
Click to read the full article.

Lubrication plays a critical role in tablet manufacturing by reducing friction between the tablet material and the compression equipment, facilitating smooth tablet ejection, and preventing sticking during the compression process. However, excessive lubrication, known as over-lubrication, can lead to a range of problems including poor tablet hardness, compromised dissolution rates, and inconsistent drug release profiles. Addressing over-lubrication is essential to ensure that tablets maintain the desired quality, appearance, and therapeutic effectiveness.
Click to read the full article.

Film coating is a critical step in pharmaceutical tablet manufacturing that applies a thin, uniform coating to the tablet’s surface to protect the active pharmaceutical ingredient (API), mask the taste, and control drug release. However, achieving uniform spray application can be challenging due to various factors like nozzle design, spray rate, and tablet movement. Inconsistent spray uniformity can lead to defects such as uneven coating thickness, rough tablet surfaces, or delayed drug release, which can impact the quality and therapeutic efficacy of the final product.
Click to read the full article.

Tablet chipping is a common issue encountered during tablet compression, where fragments of the tablet break off at the edges, resulting in defects and compromised product quality. This problem not only affects the appearance of the tablets but can also lead to issues with drug dosage consistency, product stability, and patient compliance. Tablet chipping typically occurs during the ejection phase of compression, where excessive pressure or improper ejection mechanisms can cause the tablet to break. Preventing chipping is crucial to ensure the integrity of the tablets and maintain consistent tablet hardness, weight, and drug release profiles.
Click to read the full article.